RG
GTBP icon

Retirement Group’s GT Biopharma GTBP Stock Holding History

Retirement Group’s Portfolio GTBP Stock Details GTBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$4 Hold
1
– – ﹤0.01% 843
2023
Q4 		$11 Hold
1
– – ﹤0.01% 832
2023
Q3 		$11 Hold
1
– – ﹤0.01% 775
2023
Q2 		$14 Hold
1
– – ﹤0.01% 804
2023
Q1 		$0 Hold
1
– – ﹤0.01% 711
2022
Q4 		$0 Hold
1
– – ﹤0.01% 672
2022
Q3 		$0 Hold
1
– – ﹤0.01% 615
2022
Q2 		$0 Hold
1
– – ﹤0.01% 771
2022
Q1 		$0 Hold
1
– – ﹤0.01% 774
2021
Q4 		$0 Hold
1
– – ﹤0.01% 729
2021
Q3 		$0 Hold
1
– – ﹤0.01% 657
2021
Q2 		$1K Hold
1
– – ﹤0.01% 611
2021
Q1 		$0 Buy
+1
New +$175 ﹤0.01% 757

Other funds holding GTBP

Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Retirement Group's GTBP Position: Q1 2024 in Review

Retirement Group held its GT Biopharma (GTBP) position steady in Q1 2024 at 1 share worth $4. The position accounts for ﹤0.01% of the portfolio, ranked #843.

Retirement Group first reported a position in GTBP in Q1 2021 and has held it in 13 quarters since. The position peaked at $1K in Q2 2021. 17 funds tracked by Wall St. Rank hold GTBP as of Q1 2024.

  • Retirement Group held 1 share of GT Biopharma worth $4 as of Q1 2024.
  • Retirement Group left its GT Biopharma share count unchanged in Q1 2024.
  • GT Biopharma made up ﹤0.01% of Retirement Group's portfolio in Q1 2024, its #843 holding.
  • Retirement Group first reported a position in GT Biopharma in Q1 2021 and has held it in 13 quarters since.
  • Retirement Group's GT Biopharma position peaked at $1K in Q2 2021.
  • 17 funds tracked by Wall St. Rank held GT Biopharma as of Q1 2024.

Based on Retirement Group's 13F filing for Q1 2024, filed 30 Apr 2024.